Page 1 of Clinical Trials for Drug liposomal Doxorubicin, 1333 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi's Sarcoma
Last Updated: March 14, 2012
Condition(s): Sarcoma, Kaposi
2
Completed
Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
Last Updated: April 13, 2012
Condition(s): Sarcoma, Kaposi; HIV Infections
3
Completed
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer
Last Updated: December 28, 2011
Condition(s): Breast Cancer; Drug/Agent Toxicity by Tissue/Organ; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
4
Active, not recruiting
A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
Last Updated: June 23, 2005
Condition(s): Sarcoma, Kaposi; HIV Infections
5
Active, not recruiting
Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies
Last Updated: May 18, 2011
Condition(s): Resistant Solid Malignancies
6
Active, not recruiting
Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)
Last Updated: November 21, 2011
Condition(s): Hepatocellular Carcinoma
7
Completed
Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Last Updated: June 8, 2011
Condition(s): Multiple Myeloma; Myeloma; M-Protein; Myeloma Proteins
8
Recruiting
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
Last Updated: May 24, 2012
Condition(s): Neoplasm Malignant
9
Recruiting
Ixabepilone and Liposomal Doxorubicin in Treating Women With Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer or Metastatic Breast Cancer
Last Updated: July 2, 2010
Condition(s): Breast Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
10
Completed
Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
Last Updated: April 23, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
11
Completed
Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
Last Updated: June 23, 2005
Condition(s): Sarcoma, Kaposi; HIV Infections
12
Active, not recruiting
Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse
Last Updated: October 25, 2007
Condition(s): Ovarian Cancer; Fallopian Tube Cancer
13
Active, not recruiting
Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With MM
Last Updated: February 21, 2012
Condition(s): Multiple Myeloma
14
Completed
Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors
Last Updated: May 12, 2012
Condition(s): Brain Tumor; Ewing's Sarcoma; Neuroblastoma; Rhabdomyosarcoma
15
Recruiting
Clinical Trial Of Doxorubicin Versus Trabectedin Plus Doxorubicin In The First Line Treatment Of Patients With Advanced Non Operable And/Or Metastatic Soft Tissue Sarcomas
Last Updated: April 27, 2010
Condition(s): Sarcoma
16
Terminated
Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma
Last Updated: January 24, 2012
Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
17
Recruiting
Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Last Updated: December 28, 2011
Condition(s): Ovarian Cancer; Epithelial Ovarian Cancer; Fallopian Tube Carcinoma; Primary Peritoneal Carcinoma
18
Completed
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
Last Updated: May 2, 2012
Condition(s): Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Neoplasms
19
Recruiting
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Ovarian Cancer (OC)
Last Updated: May 2, 2012
Condition(s): Ovarian Neoplasms; Peritoneal Neoplasms
20
Recruiting
Carboplatin, Pegylated Liposomal Doxorubicin Hydrochloride, and Everolimus in Treating Patients With Relapsed Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Last Updated: September 20, 2011
Condition(s): Fallopian Tube Cancer; Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+liposomal+Doxorubicin

Page 1 of Clinical Trials for Drug liposomal Doxorubicin, 1333 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About